@DavidPS said in A combination of vitamin B1/B3/B7 and aspirin, has curative effects on human mantle-cell lymphoma:
@Mauritio - Yes, it appears that he is not interested in patenting.
He selected the least expensive form of B1 to make his invention accessible to as many people as possible.
I am a registered patent attorney. I think he could obtain a patent based on the limited facts that I have. He solved a long-standing problem; that is a strong indication of patentability.
Ok in that case ,you know more about this than me.
Would be an interesting thing to ask him if he has any intentions on patenting it.